Company Valuation: Integra LifeSciences Holdings Corporation

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 5,674 4,683 3,405 1,750 967.4 1,116 - -
Change - -17.47% -27.3% -48.6% -44.72% 15.4% - -
Enterprise Value (EV) 1 6,707 5,670 4,605 3,285 2,563 2,924 2,422 2,243
Change - -15.47% -18.78% -28.66% -21.98% 14.07% -17.15% -7.4%
P/E 33.8x 26x 51.8x -252x -1.84x 29.3x 13x 10.9x
PBR 3.37x 2.6x 2.14x 1.13x 0.93x 1.31x 0.87x 0.79x
PEG - 2.86x -0.8x 2x -0x -0x 0x 0.6x
Capitalization / Revenue 3.68x 3.01x 2.21x 1.09x 0.59x 0.68x 0.67x 0.64x
EV / Revenue 4.35x 3.64x 2.99x 2.04x 1.57x 1.78x 1.45x 1.29x
EV / EBITDA 16.7x 13.8x 12.5x 10.2x 8.07x 9.1x 7.04x 6.08x
EV / EBIT 21.4x 15.5x 14x 11.7x 9.33x 10.5x 8.01x 6.81x
EV / FCF 25.4x 25.5x 63x 132x -82.5x 23.2x 13.5x 15.2x
FCF Yield 3.94% 3.92% 1.59% 0.76% -1.21% 4.31% 7.41% 6.58%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 1.98 2.16 0.84 -0.09 -6.74 0.49 1.102 1.32
Distribution rate - - - - - - - -
Net sales 1 1,542 1,558 1,542 1,611 1,635 1,644 1,675 1,737
EBITDA 1 400.7 411.3 369.7 322.2 317.5 321.2 344 368.9
EBIT 1 314.1 366.6 329.1 281.1 274.8 277.6 302.4 329.2
Net income 1 169.1 180.6 67.74 -6.944 -516.5 35.57 69.57 88.23
Net Debt 1 1,033 986.7 1,200 1,535 1,596 1,807 1,306 1,127
Reference price 2 66.99 56.07 43.55 22.68 12.42 14.35 14.35 14.35
Nbr of stocks (in thousands) 84,700 83,518 78,176 77,164 77,892 77,801 - -
Announcement Date 23/02/22 22/02/23 28/02/24 25/02/25 26/02/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution



P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
29.29x1.78x9.1x-.--% 111.64Cr
35.48x4.19x15.73x2.42% 19TCr
21.86x3.71x13.29x2.81% 12TCr
26.94x4.79x16.44x1.15% 12TCr
31.57x3.04x12.28x2.26% 9.14TCr
18.53x0.22x13.79x0.68% 6.67TCr
43.97x3.87x13.18x1.94% 5.88TCr
46.33x11.64x32.65x-.--% 5.5TCr
28.86x7.15x18.14x1.39% 4.99TCr
52.13x1.44x13.34x-.--% 3.51TCr
Average 33.50x 4.18x 15.79x 1.26% 8TCr
Weighted average by Cap. 31.86x 4.30x 15.92x 1.74%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Integra LifeSciences Holdings Corporation

Historical PBR trend

Valuation ratios - PBR - Integra LifeSciences Holdings Corporation

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Integra LifeSciences Holdings Corporation

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Integra LifeSciences Holdings Corporation


Year-on-year evolution of the Yield

Valuation ratios - Yield - Integra LifeSciences Holdings Corporation
  1. Stock Market
  2. Stocks
  3. IART Stock
  4. Valuation Integra LifeSciences Holdings Corporation